← Back to Clinical Trials
Recruiting Phase 1, Phase 2 NCT05654649

NCT05654649 Dexamethasone in the Prevention of Post-spinal Paralytic Ileus After Cesarean Section

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05654649
Status Recruiting
Phase Phase 1, Phase 2
Sponsor Assiut University
Condition Postoperative Ileus
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2022-12-01
Primary Completion 2024-12

Trial Parameters

Condition Postoperative Ileus
Sponsor Assiut University
Study Type INTERVENTIONAL
Phase Phase 1, Phase 2
Enrollment 90
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2022-12-01
Completion 2024-12
Interventions
0.9%sodium chlorideDexamethasone

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Postoperative ileus is a perplexing problem for clinical surgeons. It occurs not only after abdominal surgery but also after any surgery that requires general anesthesia. Postoperative ileus is defined as the dysfunction of gastrointestinal motility after surgery, characterized by a decrease in, or stagnation of, intestinal peristalsis.

Eligibility Criteria

Inclusion Criteria: * •All participants will sign an informed consent prior to inclusion in the study. * All patients 18-40 years of full-term singleton pregnancy (37-41 weeks)., * American Society of Anaesthesiologists (ASA) classification class I and II scheduled. * for elective or semi-elective surgery (category 3 and 4 Caesarean sections). * All patients under spinal anesthesia for a Single baby pregnancy of more than 32 weeks will be included in this study. Exclusion Criteria: * will be patients' height \< 150 or \> 180 cm. * Body mass index (BMI) \>35 kg m-2. * Contraindication or refusal to undergo regional anesthesia. * any cardiovascular disease including arrhythmias and severe stenotic valvular heart disease.any renal or hepatic diseased patients.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology